OneMed Intensively Produces Medical Devices For The Nation's Children To Support National Independence

Illustration. (Photo: Doc. Antara)

JAKARTA - The Ministry of Health noted that the number of medical device products (alkes) from abroad circulating in Indonesia reached 154,041 or around 87.3 percent, much larger than local products which were only 22,422 or 12.7 percent until July 2022.

Meanwhile, the Ministry of Finance reports that the total imports of medical devices (alkes) in 2021 will reach Rp. 9.17 trillion with a total incentive facility of Rp. 1.79 trillion, almost 20 percent or one-fifth of the import value of medical products.

Moreover, President Joko Widodo, since the end of 2021, has also warned that Indonesia does not continue to import medicines and medical devices so that Indonesia is more independent in the health sector.

The potential of the medical device industry is not kidding because it is related to Indonesia's population of 270 million people, in which the proportion of middle class households is projected to reach 30.2 percent in 2026, from around 29.7 percent in 2020 in line with the easing of the pandemic. IMF, WEO April 2022).

During the period from January 1 to June 30, 2022, the Ministry of Finance also noted that the import value of medical equipment reached Rp.887 billion with total facilities or incentives of Rp.202 billion, or about 22 percent of the total import value.

Meanwhile, the ratio of health spending to GDP in Indonesia in 2015 and 2021 (projected) is 2.9 percent and 3.2 percent, respectively, again far from Japan which reached 10.7 percent and 12.3 percent.

In fact, according to IMF estimates (in the April 2022 WEO), the compound annual growth rate (CAGR) of Indonesia's nominal GDP from 2021 to 2026 will reach 7.1 percent (compared to the 2015-2021 CAGR of 4.4 percent). far beyond Japan's projected 4.7 percent.

No wonder the CAGR growth in sales of medical devices in the country is predicted to reach 10.1% in the period from 2021 to 2026, from only Rp. 57 trillion in 2020 to Rp. 102.2 trillion in 2026.

Commitment of PT Jayamas Medica Industri or OneMed

PT Jayamas Medica Industri (JMI), known as the OneMed brand, was founded by Dr Jemmy Hartanto in 2000 in East Java, as one of the leading manufacturers of integrated medical devices in the country.

As a consumable medical device company with the most locally made products in Indonesia, PT Jayamas Medica Industri continues to aggressively expand to maintain growth throughout 2019-2021.

In 2006, Dr Jemmy Hartanto expanded the Krian factory into an 8,000 square meter facility with 500 employees and added disposable syringes to the company's portfolio.

Furthermore, the company succeeded in obtaining ISO 13485 certification for Quality Management System for Medical Devices and received the certification of Good Manufacturing and Distribution of Medical Devices (CPAKB) from the Indonesian Ministry of Health in 2013.

Next, Jayamas Medica has received ISO 9001 qualification on Quality Management System since 2005 until now.

Armed with these two quality controls, in 2016, Dr Jemmy Hartanto was confident to establish a second factory in Mojoagung with a total land area of 23,707 square meters and also began to accumulate a land bank in Lamongan, East Java, to anticipate the company's expansion in the future.

In the following year, Jayamas received the Indonesian Health Sector Award from the Ministry of Health and the Local Creation Award for Pharmacy and Medical Equipment for the Uro OneFoley-Catheter. In 2020, Dr Jemmy Hartanto began restructuring to consolidate the Group's business so that the company now owns 99% shares of PT Intisource Hasil Sempurna Global (IHSG), which runs the distribution business line previously held by PT Intisource Hasil Sempurna (IHS).

Also this year, Jayamas provided 50 million pieces of alcohol swabs as full support for the Ministry of Health in responding to the COVID-19 pandemic, in addition to receiving the EC (European Conformity) certificate for Medical Devices Production Quality Assurance from TÜV Rheinland for single-use syringes with needles and syringes. Disposable syringe without needle.

In 2021, Jayamas Medica Industri acquired a 51% stake in PT Inti Medicom Retailindo, the company's retail business line in offline and online retail stores and acquired a land bank in Mojoagung for the Mojoagung II and Wonosalam factories and completed land accumulation for a land bank in Lamongan.

Through a long journey in developing these facilities, Jayamas Medica now has at least 3,200 active stock keeping units (SKUs) scattered across six categories (as of March 31, 2022).

"In 2021, the segment that contributes the most to the company's revenue is the Medical Disposable and Consumables category with 64.6 percent, followed by Antiseptic and Dialysis (13.8 percent), Diagnostic and Equipment (13.6 percent), Biotechnology and Laboratory (4 .2 percent), Hospital Furniture (2 percent), and Walking Aids and Rehabilitation (1.8 percent)," said JMI founder and President Commissioner Dr Jemmy Hartanto, in his statement, quoted Monday 15 August.

Nearly two decades of operation, Jayamas now has 1 distribution center in Gresik, East Java, 20 branch offices/warehouses, and 19 sales offices spread across Java, Kalimantan, Sulawesi and Sumatra (as of March 31, 2022). The company's total land bank that is ready to be used for expansion is more than 163,719 square meters.

In addition, the company also supplies 1,700 hospitals in Indonesia, out of a total of around 2,985 hospitals. The company also cooperates with 3,475 pharmacies and medical device outlets.

Meanwhile, Marketing Director of PT Jayamas Medica Industri, Louis Hartanto, said the company plans to add 1 new distribution center in Jakarta, bringing a total of 2 distribution centers. In addition, the company will also build 15 new warehouses in a number of key locations to streamline and streamline the process.

PT Jayamas Medica Industri is now also listed as the largest producer of consumable medical devices made by the nation's children with 493 Indonesian products or 4.87 percent of the total 10,109 medical devices registered with the Ministry of Health.

In 2022, in order to increase the penetration of medical devices made by the nation's children to all corners of Indonesia, the company is ready to expand by developing facilities on company-owned land in Mojoagung II, Wonosalam Jombang, and Lamongan as well as building new facilities in the Batang Integrated Industrial Estate or KITB.